Jiuyuan Yinhai: the holding subsidiary has passed the CMMI5 evaluation and certification
Jiuyuan Yinhai announced that Sichuan Xingzheng Information Technology Co., Ltd., the holding subsidiary of the company, recently passed the CMMI5 evaluation certification and obtained the certificate, which is valid until November 12, 2024. CMMI (Capability Maturity Model Integration) is the integration of software capability maturity model. Passing CMMI certification is an important symbol to measure the R & D ability of enterprise software engineering. CMMI model level is divided into five levels, and CMMI maturity level 5 is the optimization management level, which is the highest level.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Healthcare, Financials
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Briefing Feb 17, 2022 10:08 AM
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
Briefing Jan 24, 2022 02:39 PM
The main force continued to increase its position in lithium battery stocks in the late trading, and sold off banks and pharmaceutical stocks
Briefing Jan 14, 2022 02:18 PM
· Healthcare
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
See more
Read next
Insight
In-depth
Automotive · Analysis
How Malaysia Became Southeast Asia’s “Computing Power Hub”
Jan 07, 2026 12:24 PM
Insight
In-depth
Automotive · Analysis
Consumer-Grade 3D Printing Going Global Is Reaching a Watershed
Dec 29, 2025 05:40 PM
Insight
In-depth
Automotive · Analysis
Unpacking China | Key Chinese Firms to Watch This Week （14/12/2025-20/12/2025）
Dec 19, 2025 03:50 PM
Insight
In-depth